Investors in Roche can expect a huge dividend payment. Based on the recent analysts' consensus the stock now has one of the highest dividend returns of the Swiss market. Per share the analysts anticipate on a dividend of 8,7 CHF per share. The dividend yield is then 3,39 percent. The average dividend yield of the pharmaceutical companies equals a limited 0,5 percent.
Tomorrow the Swiss Roche will publish its past quarters figures. For this year Roche's revenue will be around 56,97 billion CHF. This is according to the average of the analysts' estimates. This is slightly more than 2017's revenue of 53,3 billion CHF.
The analysts expect for 2018 a net profit of 15,3 billion CHF. According to most of the analysts the company will have a profit per share for this book year of 17,67 CHF. The price-earnings-ratio equals 14,52.
Roche's market capitalization is based on the number of outstanding shares around 177,55 billion CHF. The Roche stock was the past 12 months quite volatile. Since last January the stock is 15 percent higher. This year the stock price moved between 206 and 260 CHF. Since 2008 the stock price is almost 57 percent higher.On Tuesday the stock closed at 256,6 CHF.
ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.